Filing Flows › uniQure N.V. (QURE) › Recalls, complaints & regulation
uniQure N.V. (QURE): clinical trials
uniQure N.V. (QURE) beyond its filings: 5 active clinical trials.
uniQure N.V.'s latest quarter
uniQure N.V., Q3 2026: revenue $5.2M (+40% year over year), net loss $61.2M, operating cash flow −$47.8M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does uniQure N.V. have?
5 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.